When giving supplemental oxygen to a COPD patient, what should you watch for?

When giving supplemental oxygen to a COPD patient, what should you watch for?

• A. CO2 narcosis leading to hypoventilation and respiratory acidosis
• B. Immediate improvement without risk
• C. Worsening cough due to mucus production
• D. Increased risk of pneumothorax

Answer: (D)

When giving supplemental oxygen to a COPD patient, the main thing to watch for is CO2 retention leading to hypoventilation and respiratory acidosis. Many COPD patients live with chronic CO2 retention; providing too much oxygen can blunt the hypoxic drive that helps stimulate breathing, causing a drop in ventilation and a rise in PaCO2. This can precipitate acute hypercapnic respiratory failure if not recognized. Clinically, watch for changes in mental status (confusion, somnolence, headaches), worsening dyspnea in the setting of high oxygen flow, and signs on monitoring or ABG showing rising CO2 with a falling or low-normal pH. To minimize risk, titrate oxygen to the lowest level that achieves a target saturation (often about 88–92%), and monitor with pulse oximetry and, if indicated, arterial blood gases. If CO2 retention occurs, adjust oxygen appropriately and consider noninvasive ventilation if needed. Pneumothorax can occur in COPD due to ruptured bullae, but it is not the primary issue caused by oxygen therapy itself; it remains a separate complication with its own warning signs (sudden chest pain, unilateral breath sounds changes). Worsening cough or immediate, risk-free improvement are not the best descriptors of the main concern with oxygen in COPD.

When giving supplemental oxygen to a COPD patient, the main thing to watch for is CO2 retention leading to hypoventilation and respiratory acidosis. Many COPD patients live with chronic CO2 retention; providing too much oxygen can blunt the hypoxic drive that helps stimulate breathing, causing a drop in ventilation and a rise in PaCO2. This can precipitate acute hypercapnic respiratory failure if not recognized.

Clinically, watch for changes in mental status (confusion, somnolence, headaches), worsening dyspnea in the setting of high oxygen flow, and signs on monitoring or ABG showing rising CO2 with a falling or low-normal pH. To minimize risk, titrate oxygen to the lowest level that achieves a target saturation (often about 88–92%), and monitor with pulse oximetry and, if indicated, arterial blood gases. If CO2 retention occurs, adjust oxygen appropriately and consider noninvasive ventilation if needed.

Pneumothorax can occur in COPD due to ruptured bullae, but it is not the primary issue caused by oxygen therapy itself; it remains a separate complication with its own warning signs (sudden chest pain, unilateral breath sounds changes). Worsening cough or immediate, risk-free improvement are not the best descriptors of the main concern with oxygen in COPD.